Related Herbs
Botanicals connected by the same goals, effects, or research topics.
Compound Profile
Diosgenin
Steroidal sapogenin from wild yam and fenugreek used as pharmaceutical synthesis precursor for steroid hormones.
Use extra caution — Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details
Last reviewed: •1 source citedReport a correctionProfile-wide ·C Limited
At a glance
From this profile's structured data- Evidence
- Grade C
- Safety
- Safety evidence: limited human evidence for a diosgenin-rich yam extract, not isolated diosgenin.
- Profile context
- PPAR signaling, lipid metabolism, inflammatory cytokines
Next stepsWhere to go next — guides & comparisons
Continue reading
- If you want to browse more compounds → All compounds
Quick stats
- Evidence level
- Limited evidence
- Typical onset
- Varies by prep
- Safety rating
- Use extra caution: Interaction risk
- Best for
- PPAR Signaling, Lipid Metabolism, Inflammatory Cytokines
Botanical Context
Source botanicals and comparison guides related to Diosgenin.
Compare active botanicals
Safety
Safety & Cautions
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Interaction-AwareMedication or interaction context is explicitly noted.
- Liver-SensitiveLiver-related caution language appears in the profile.
- Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
- Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
- Safety evidence
- limited human evidence for a diosgenin-rich yam extract, not isolated diosgenin
- Who should avoid this?
- No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
- Talk to a professional if
- you use relevant medications, you are pregnant or breastfeeding, you have a condition named in this safety summary.
A 12-week trial reported no adverse effects, but isolated-compound endocrine, pregnancy, breastfeeding, bleeding, blood-sugar, liver, kidney, and medication-interaction safety remain insufficient.
Evidence Summary
Profile-wide ·C LimitedEvidence lens
Read as directional context, not settled clinical proof.
LimitedLimited evidence
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Metabolic Regulation · Immune Signaling Modulation
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
This profile cites 1 human study.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Diosgenin has a limited evidence rating.
General wellnessGeneral wellness
Citation density
0.3
Sources
1
Effects
4
Research recency
Mixed recency
Evidence Grade
Grade C: Limited Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta analysis
- Risk of Bias
- Low
- Consistency
- Not assessed
Strongest recorded design is a meta analysis, drawn from 2 recorded studies, 1 in people.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (1)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
What the evidence actually shows
This table contains 1 structured source, including 0 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives Semwal P et al. · Oxid Med Cell Longev · 2022 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
How Diosgenin Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Diosgenin Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Dosing
- Common form
- capsule or standardized extract
- No standardized dose
- Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
- Inflammatory Signaling Modulation
- Metabolic Regulation
- Immune Signaling Modulation
- Lipid Metabolism Support
- Lipid Metabolism
Guides that use Diosgenin
Condition guides
Continue exploring
Related research paths
Related Compounds
Compounds connected by the same goals, effects, or research topics.
Related Guides
Deeper context, comparisons, and practical research paths.
Related Safety Pages
Safety checks and cautions relevant to this decision.
Related Articles
Deeper context, comparisons, and practical research paths.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Free safety checklist
Get the Diosgenin evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?